A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,043,761 shares of EW stock, worth $70.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,043,761
Previous 1,050,389 0.63%
Holding current value
$70.7 Million
Previous $97 Million 29.01%
% of portfolio
0.17%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$59.7 - $93.78 $395,691 - $621,573
-6,628 Reduced 0.63%
1,043,761 $68.9 Million
Q2 2024

Jul 29, 2024

SELL
$84.3 - $94.31 $11 Million - $12.3 Million
-130,079 Reduced 11.02%
1,050,389 $97 Million
Q1 2024

May 08, 2024

SELL
$72.54 - $95.56 $2.66 Million - $3.5 Million
-36,645 Reduced 3.01%
1,180,468 $113 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $20.9 Million - $26.3 Million
-338,074 Reduced 21.74%
1,217,113 $92.8 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $9.2 Million - $12.4 Million
-132,796 Reduced 7.87%
1,555,187 $108 Million
Q2 2023

Aug 08, 2023

BUY
$81.41 - $94.33 $30.5 Million - $35.4 Million
374,985 Added 28.56%
1,687,983 $159 Million
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $7.47 Million - $8.51 Million
100,656 Added 8.3%
1,312,998 $109 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $2.64 Million - $3.38 Million
-38,601 Reduced 3.09%
1,212,342 $90.5 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $3 Million - $3.91 Million
36,467 Added 3.0%
1,250,943 $103 Million
Q2 2022

Aug 04, 2022

BUY
$86.5 - $128.27 $15.1 Million - $22.3 Million
174,144 Added 16.74%
1,214,476 $115 Million
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $20 Million - $25.1 Million
195,893 Added 23.2%
1,040,332 $122 Million
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $8.89 Million - $10.9 Million
-83,548 Reduced 9.0%
844,439 $109 Million
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $7.12 Million - $8.49 Million
-69,147 Reduced 6.93%
927,987 $105 Million
Q2 2021

Aug 05, 2021

BUY
$83.84 - $104.76 $6.34 Million - $7.92 Million
75,623 Added 8.21%
997,134 $103 Million
Q1 2021

May 05, 2021

BUY
$78.68 - $90.67 $2.28 Million - $2.62 Million
28,930 Added 3.24%
921,511 $77.1 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $6.46 Million - $8.22 Million
90,085 Added 11.23%
892,581 $81.4 Million
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $10.3 Million - $13.4 Million
-153,703 Reduced 16.07%
802,496 $64.1 Million
Q2 2020

Aug 04, 2020

BUY
$57.54 - $76.95 $36.4 Million - $48.6 Million
632,002 Added 194.94%
956,199 $66.1 Million
Q1 2020

May 12, 2020

BUY
$52.41 - $81.0 $3.71 Million - $5.73 Million
70,778 Added 27.93%
324,197 $61.2 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $658,923 - $754,407
-9,190 Reduced 3.5%
253,419 $59.1 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $545,579 - $668,611
8,864 Added 3.49%
262,609 $57.8 Million
Q2 2019

Aug 02, 2019

BUY
$55.74 - $64.41 $2 Million - $2.31 Million
35,808 Added 16.43%
253,745 $46.9 Million
Q1 2019

Apr 26, 2019

SELL
$47.89 - $64.05 $1.61 Million - $2.15 Million
-33,602 Reduced 13.36%
217,937 $41.7 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $829,253 - $1.02 Million
-17,868 Reduced 6.63%
251,539 $37.8 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $34,457 - $43,754
-754 Reduced 0.28%
269,407 $46.9 Million
Q2 2018

Aug 01, 2018

SELL
$42.45 - $51.3 $4.38 Million - $5.3 Million
-103,285 Reduced 27.66%
270,161 $39.3 Million
Q1 2018

May 07, 2018

SELL
$37.19 - $47.45 $5.8 Million - $7.4 Million
-155,942 Reduced 29.46%
373,446 $52.1 Million
Q4 2017

Feb 01, 2018

SELL
$33.79 - $39.39 $427,274 - $498,086
-12,645 Reduced 2.33%
529,388 $59.7 Million
Q3 2017

Nov 02, 2017

BUY
$36.29 - $38.83 $19.7 Million - $21 Million
542,033
542,033 $59.2 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.